Therapeutic Effects of Synthetic Antimicrobial Peptides, TRAIL and NRP1 Blocking Peptides in Psoriatic Keratinocytes

Psoriasis is a chronic, recurrent, heterogeneous, cutaneous inflammatory skin disease for which there is no cure. It affects approximately 7.5 million people in the United States. Currently, several biologic agents that target different molecules implicated in the pathogenic processes of psoriasis a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ryu, Sunhyo, Broussard, Lindsey, Youn, Chakyung, Song, Brendon, Norris, David, Armstrong, Cheryl A., Kim, Beomjoon, Song, Peter I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chonnam National University Medical School 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536438/
https://www.ncbi.nlm.nih.gov/pubmed/31161119
http://dx.doi.org/10.4068/cmj.2019.55.2.75

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536438/
https://www.ncbi.nlm.nih.gov/pubmed/31161119
http://dx.doi.org/10.4068/cmj.2019.55.2.75

Ejemplares similares